Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision (2018)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.stemcr.2018.11.001
PubMed Identifier: 30503262
Publication URI: http://europepmc.org/abstract/MED/30503262
Type: Journal Article/Review
Parent Publication: Stem Cell Reports
Issue: 6
ISSN: 2213-6711